News 2019

Age is one of the biggest risk factors for cardiovascular diseases. Scientists at the German Centre for Cardiovascular Research (DZHK) have now investigated what happens deep in the heart when it ages. They have studied the cells from thousands of old and young hearts to compare...

Congratulations!

In 2019, these DZHK members are among the one percent of the most cited scientists worldwide.

Scientists from the German Centre for Cardiovascular Research (DZHK) at the partner site Heidelberg University Hospital have discovered how a small molecule in the heart – responsible for protecting the heart’s pumping action - is produced in mouse heart muscle cells. This...

To a larger extent than previously considered in medicine, elevated levels of cholesterol increase the long-term risk of suffering a heart attack; in particular for young people. This has been proven by a study completed by researchers at the University Heart & Vascular Centre....

Without patients participating in clinical trials, we could make no progress in medicine. Nowadays, all treatment decisions are made based on controlled clinical data. The German Centre for Cardiovascular Research (DZHK) has published a video for patients to increase their trust...

On 1 January 2020, the cardiologist from the Munich University Hospital succeeds Prof. Gerd Hasenfuß on the DZHK Board of Directors, who is leaving at the end of the year.

Sudden cardiac death causes great suffering and raises many questions. It is therefore a focus of research at the German Centre for Cardiovascular Research. Professor Axel Bauer, University Hospital Munich and Medical University Innsbruck, explains who is at risk of sudden...

Twelve European partners have joined forces to tackle one of the biggest challenges in cardiovascular medicine: the regeneration of lost heart muscle cells. The partners will together receive €8 million from the European Horizon 2020 programme for the REANIMA project. The DZHK...

After a heart attack or unstable angina pectoris, antiplatelet treatment with prasugrel is better for patients than with ticagrelor. This is the unexpected result of ISAR-REACT 5, an industry-independent study funded by the German Centre for Cardiovascular Research (DZHK) and the...

A German and British research team lead by the Technical University of Munich (TUM) has examined the interplay between genetics, cardiovascular disease and educational attainment in a major population study. Genetic variants which had been linked to educational attainment in...